Good news about the treatment of Alzheimer’s disease is hard to find. However, new breakthrough research is hailed as the “best news” in dementia research for 25 years and a potential “game changer” for people with the disease. In a preliminary trial a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins—a hallmark of Alzheimer’s—from the brain. Compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function.
Experimental drug slows memory loss and halts Alzheimer’s decline
More of Today's Solutions
How paying people to protect a rainforest is rewriting colonial history on a ...
BY THE OPTIMIST DAILY EDITORIAL TEAM For centuries, the tiny West African island of Príncipe was a place where nature was exploited and people ...
Read MoreHow to find your personal aesthetic when the internet keeps showing you every...
BY THE OPTIMIST DAILY EDITORIAL TEAM Style has a way of feeling most elusive exactly when you're looking for it. You know what you're ...
Read More3 amazing environmentally friendly leather alternatives
The global demand for leather takes a lot of cattle which are cruelly treated and contribute a great deal of greenhouse gasses. Not only ...
Read MoreHow low can you go? The benefits of squatting like a toddler
Squats are a staple of most workout routines (especially on leg days), but what about a deep resting squat? That isn't always a go-to, ...
Read More
